Mesotherapy for hair loss: evidence, risks, and how to decide
Ariana Wen
September 18, 2026
Key takeaways
Mesotherapy for hair loss microinjects medications or vitamins into the skin.
Your type of hair loss should be assessed before treatment is chosen.
Standard protocols and controlled data remain limited. For pattern loss, your needs, likely adherence, budget, extent of loss, and goals matter.
When hair loss worries you, a treatment promise can feel like a welcome answer. Yet "mesotherapy" is a broad term, so you still need to know what is being offered. A useful plan names the product, the goal, the risks, the timing, and the way change will be tracked.
Your type of hair loss matters just as much. Once you know the likely cause, you can compare a defined mesotherapy plan with medication, PRP, and microneedling on fair terms.
Mesotherapy is a delivery method, not a complete treatment description
The name tells you how a substance reaches the skin, but it does not identify the substance or define the whole plan. Hair mesotherapy microinjects medications or vitamins into the middle layer of the skin. Traditional plans may use nutrients, peptides, or biomimetic compounds intended to support follicle activity, the skin barrier, or blood supply. Mesotherapy also remains distinct from PRP and exosome preparations, even when small injections or microneedling are used to deliver those preparations.
Your seven-point mesotherapy specification sheet
Part of the proposal | What to record and why it helps |
|---|---|
1. Proposed substance | Record the exact medication, vitamin, nutrient, peptide, or biomimetic compound in the proposal. The word mesotherapy alone does not identify what would be injected. |
2. Delivery method | Record how the substance would be delivered. Mesotherapy is separate from PRP and exosome preparations, even though those preparations may also be delivered through microinjections or microneedling. |
3. Scalp suitability | The assessment should check for active scalp inflammation or infection. When risk factors are present, it should also review iron status, vitamin D, thyroid function, blood glucose, and liver function. |
4. Canadian authorization | Ask to see the product label and check that the injectable health product is authorized for sale by Health Canada. This check applies to the product that may be injected. |
5. Expected outcomes and risks | Hair-mesotherapy consent should cover the expected result and risks. Record the specific change being discussed and the risks tied to the proposed product and delivery method. |
6. Time frame | Consent should also cover the time frame. Record when the treatment course would begin and end, and when any change would first be assessed. |
7. Reassessment point | One expert protocol checks progress after 12 weeks using trichoscopy, patient-reported outcomes, and clinical photography. In that protocol, treatment stops at month 6 if there is no improvement. Record the measures and stop point proposed for your plan. |
The final row is an example from one expert protocol, not a universal schedule for every formulation. It shows why a treatment proposal needs a named measure and a review point. Without those details, two plans called mesotherapy may be difficult to compare.
The cause of hair loss changes the treatment decision
The cause of hair loss should be assessed before you approach a commercial hair clinic. Some types are permanent, while others are temporary. That first distinction changes what you are trying to treat.
Temporary loss can be linked with illness, stress, cancer treatment, weight loss, or iron deficiency. Telogen effluvium is one type of temporary loss. It is non-scarring and can reverse on its own, so it presents a different problem from lasting pattern loss.
Androgenetic alopecia is also called pattern hair loss. In this condition, dihydrotestosterone helps make hair follicles smaller and shortens each new growth cycle. This process applies to androgenetic alopecia, not every cause of shedding.
Your first task is to understand which cause is being considered. You can then ask whether the proposed treatment is meant for that condition. An ingredient may be intended to support the follicle, skin barrier, or blood supply, but that intended action is only one part of the fit.
Questions that bring the cause into focus
What cause of hair loss is being considered?
Is the loss thought to be short-term or lasting?
Is pattern hair loss part of the assessment?
Is there active inflammation or infection on the scalp?
Do my risk factors make an iron or vitamin D review relevant?
Do my risk factors make a thyroid, blood glucose, or liver review relevant?
What part of the proposed plan is meant to fit this cause?
Which change will be tracked if I go ahead?
These questions are especially useful when the treatment name sounds more specific than it is. They keep the focus on your condition, rather than asking one procedure to fit every form of hair loss.
What do measured results show?
Measured results do not support one blanket answer because standardized hair-mesotherapy protocols and controlled clinical data for androgenetic alopecia remain limited. A result must be read within the population, formulation, delivery method, schedule, comparator, and measurement point that were tested.
Evidence and safety audit
Study setting | AGA population and protocol | Measurement point | Finding |
|---|---|---|---|
Randomized active-controlled trial | 49 males with androgenetic alopecia. One group received eight sessions of an injected mesosolution with microneedling. The other used 5% topical minoxidil twice daily for four months. | Dermoscopy, Trichoscan, and patient views were used in the comparison. | Most measures did not differ significantly between the groups. Mesotherapy did not show significant improvement over minoxidil for male androgenetic alopecia in this trial. |
Retrospective observational study without a control group | 50 patients with androgenetic alopecia received eight mesogun sessions over three months. Each session delivered 3 mL of a solution containing biomimetic peptides, vitamins, and micronutrients. | Trichoscopy and Trichoscan measurements were taken four weeks after the final session. | Hair density, average hair thickness, and terminal hair density improved in this 50-patient protocol. |
Clinic before-and-after images may show one person's appearance at two points, but they do not establish typical effectiveness. Patient reviews and Reddit reports do not establish it either. They should not be treated as substitutes for measurements from a defined protocol and population.
At-home use, cost, and claims about a "best formulation" answer different questions. The findings above should not be widened into an at-home recommendation or proof that one formulation is best. Budget can matter when choosing treatment for androgenetic alopecia, but it is a personal selection factor, not an efficacy result.
Make the proposed result clear
Use these prompts when a result is discussed:
What exact change is expected?
Will hair density be checked?
Will average hair thickness be checked?
Will terminal hair density be checked?
Will trichoscopy be used?
Will patient reports or clinical photos be used?
When will the first check take place?
What will count as improvement?
Is there a clear point to stop when change is absent?
Does the research involve the same type of hair loss?
Does it use the same product and amount?
Does it use the same tool and number of sessions?
Was the result compared with another treatment?
A clear goal can spare you from judging progress by memory alone. It also lets you compare what was promised with the same measure at the review point.
What are the downsides of mesotherapy for hair loss?
Local side effects and reactions can occur. The product and plan matter, so ask about the risks tied to the exact proposal.
Evidence and safety audit: local reactions
Setting | What was reported | What it means for the proposal |
|---|---|---|
Mesotherapy in general | Ask which local reactions are linked with the named product and delivery method, and weigh them against the expected result and time frame. | |
One 50-patient AGA protocol | The protocol used biomimetic peptides, vitamins, and micronutrients. The reported side effect was mild, short-lived pain. | Mild, short-lived pain was reported only for this protocol. It does not establish safety for a different formulation or at-home use. |
There is a second downside when a plan is hard to define. It is difficult to weigh a risk against a vague goal. Hair-mesotherapy consent should cover the expected result, risks, and timing, so those points should be clear before treatment starts.
The time and budget also deserve thought. Published trials have used 3–6 sessions, while the two AGA reports above used eight. Your likely follow-through and budget are part of treatment selection for androgenetic alopecia.
A short risk check
Can I name the product that would be injected?
Have I seen its label?
Is it authorized for sale by Health Canada?
What local reactions can occur with this plan?
What result am I weighing against those risks?
How many visits does the proposed plan involve?
When will progress be checked?
What is the stop point if I see no change?
Is mesotherapy for hair loss effective, and how does it compare with other options?
The best fit depends on your diagnosis and daily life. For androgenetic alopecia, treatment choice should consider your needs, likely follow-through, budget, extent of loss, and aesthetic goals.
Diagnosis-to-option comparison
Option | People or research setting | Measured role or result | Main limit or tradeoff |
|---|---|---|---|
Mesotherapy | Published hair-mesotherapy trials and specific AGA plans. The product, tool, and schedule can vary. | Trials have reported gains in hair density and shaft thickness after 3–6 sessions. Short-lived pain and redness were reported most often. | Standard methods and controlled data remain limited for AGA. A male trial found no significant gain over minoxidil on most measures. The exact proposal still needs a product, goal, risk, time frame, and review point. |
Medication | Pattern hair loss. Drug treatment centres on minoxidil and finasteride. Topical minoxidil is the first-choice drug with strong support for female-pattern loss. | Medication has a defined role in pattern hair loss. The male comparison used 5% topical minoxidil twice a day for four months. | About 40% of patients with female-pattern loss do not improve with topical minoxidil. It can cause scalp redness, discomfort, burning, and extra shedding through minoxidil-induced telogen effluvium. |
PRP | Hair-restoration research. PRP uses a source of growth factors taken from your own blood. It is different from mesotherapy even when both use scalp injections. | PRP research has found signs of renewed hair growth. | Small groups and varied methods leave its results partly settled. Our PRP hair-treatment cost guide deals with the budget for PRP, which is separate from mesotherapy cost. |
Adjunct microneedling | Combined or add-on care across varied hair-loss types, devices, needle depths, and schedules. | Combined care improved hair density and width compared with one treatment alone. Add-on use has also improved hair measures in varied settings. | These findings cover combined or add-on care. Ask what microneedling would be paired with in the proposed plan. Our microneedling before-and-after guide offers more context on the treatment. |
Each option asks something different of you. Medicine may depend on regular use, while a procedure plan may involve a set of visits. Your likely follow-through belongs in the choice, along with your budget, extent of loss, needs, and goals.
Build your own short list
Ask these questions before you compare options:
What type of hair loss am I trying to treat?
Is that type short-term or lasting?
How far has the loss progressed?
What result matters most to me?
Which result can be measured in a clear way?
How often would I need to use the drug or attend a visit?
How well can I keep up with that plan?
What is the full time frame?
What does the plan ask of my budget?
Which side effects or local reactions may occur?
When will the result be reviewed?
What would lead to a change or stop in the plan?
If you want help with your choice, book a consultation through our North York hair-restoration page.